ABL BIOTEC A/S: Financial statements 2019
CVR: 50811018
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
ABL BIOTEC A/S (CVR 50811018) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -114,364 and a net result of DKK 3,308,337 compared with DKK -1,956,129 the year before. Equity in the 2019 report amounted to DKK 24,721,830. The solvency ratio was 98.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -114,364
- Profit/Loss
- DKK 3,308,337
- Equity
- DKK 24,721,830
- Total Assets
- DKK 25,177,844
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -114 t. | 3.3 mio. | 24.7 mio. | 1 |
| 2018 | - | -109 t. | -2 mio. | 21.5 mio. | 1 |
| 2017 | - | -125 t. | 1.1 mio. | 24.6 mio. | 1 |
| 2016 | - | -118 t. | 796 t. | 24.5 mio. | 1 |
| 2015 | - | -122 t. | 2.2 mio. | 24.8 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
ABL BIOTEC A/S has published its annual report for 2018. Gross profit came to DKK -109,236, and the net result was DKK -1,956,129.
About ABL BIOTEC A/S
ABL BIOTEC A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Asger Bach-Larsen. The board consists of Kirsten Bach-Larsen (chair), Gitte Larsen and Rikke Dahl Andersson. The company is owned by Asger Bach-Larsen and Kirsten Bach-Larsen. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK -129,949 and a net result of DKK -116,723 compared with DKK 3,704,421 the year before. Equity in the 2025 report amounted to DKK 27,884,586.